Safety and Efficacy of Nusinersen and Risdiplam for Spinal Muscular Atrophy: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Objective: We performed a systematic review and meta-analysis of the efficacy and safety of nusinersen and risdiplam in the treatment of spinal muscular disease (SMA). Methods: We screened the literature published in Pubmed, Web of Science, Embase, and Cochrane before July 2023 to conduct randomized...

Full description

Bibliographic Details

Published in:	Brain Sciences
Main Authors:	Yue Qiao, Yuewei Chi, Jian Gu, Ying Ma
Format:	Article
Language:	English
Published:	MDPI AG 2023-10-01
Subjects:	spinal muscular atrophy nusinersen risdiplam meta-analysis efficacy safety
Online Access:	https://www.mdpi.com/2076-3425/13/10/1419